FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to therapy and aims at choosing a therapeutic approach to osteopenia. It involves densitometric evaluation of the bone mineral density. It is combined with single-energy densitometric visualisation of the spine in a lateral projection. When observing a body height decrease of at least one vertebra by 20% and more, drug treatment is the same as applied in complicated osteoporosis. If vertebral body height decrease is less than 20%, the preventive actions to suppress bone content are held.
EFFECT: method allows to develop an adequate therapeutic approach to osteopenia for a short period of time to enable specific antiosteoporotic preparations to be prescribed, if necessary, to prevent fractures in lower radiation exposure.
2 ex, 2 tbl, 3 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING POSTMENOPAUSAL OSTEPOROSIS | 2009 |
|
RU2424815C2 |
| METHOD OF TREATING VERTERBROGENIC PAIN SYNDROME WITH UNDERLYING OSTEOPOROSIS | 2011 |
|
RU2466705C1 |
| AGENT FOR LOW-TURNOVER METABOLIC BONE DISEASE IN PATIENTS WITH CHRONIC RENAL INSUFFICIENCY | 2012 |
|
RU2491940C1 |
| METHOD FOR CORRECTING BONE TISSUE STATUS AND PREVENTING FRACTURES IN CARDIOVASCULAR PATIENTS | 2013 |
|
RU2552300C2 |
| METHOD FOR PREDICTION OF RISK OF OSTEOPOROTIC FRACTURES IN WOMEN IN POSTMENOPAUSAL PERIOD | 2015 |
|
RU2602060C1 |
| AGENT FOR LOW-METABOLIC BONE DISEASE IN PATIENTS WITH CHRONIC RENAL INSUFFICIENCY | 2012 |
|
RU2485957C1 |
| METHOD OF ASSESSING MINERAL DENSITY OF BONE TISSUE IN PATIENTS WITH CHRONIC HEART FAILURE | 2013 |
|
RU2565833C2 |
| DIAGNOSTIC TECHNIQUE FOR TUMOUR INVOLVEMENT OF SPINAL COLUMN | 2014 |
|
RU2547081C1 |
| METHOD FOR DETERMINING OPTIMAL INTERVAL BETWEEN OPERATIONS OF ENDOPROSTHESIS DURING BILATERAL HONARTHROSE OR COXARTHROSIS IN PATIENTS WITH OSTEOPOROSIS | 2016 |
|
RU2632705C1 |
| METHOD OF TREATMENT OF OSTEOPOROSIS IN WOMEN IN POSTMENOPAUSE AGAINST THE BACKGROUND OF OBESITY | 2017 |
|
RU2657789C1 |
